Will You Take The Vaccine?

Are you going to take the corona virus vaccine?

  • No.

  • Yes.

Results are only viewable after voting.
CunningCanuk

CunningCanuk

Well-Known Member
Alter Jean said:
Word! Thanks for that.
Was kinda nervous to ask such a dumb question but figured if someone knew it would be in this thread here.
It's been bugging me for quite some time. (The get together was a months ago)



Wait I was typing my response and now I am between the two. I'm still getting the shot but was curious if it could even work that way.
I've been thinking about it a lot

I'm not trying to start an arguement or anything. This is just one case and one question I had about a lil BBQ get together in which everyone had partial vax except me.. I wouldn't have smoked if they told me. I swear it was a setup. Always been the black sheep
Click to expand...
It’s probably not a good idea to get medical advice from a rodeo clown.
 
Budley Doright

Budley Doright

Well-Known Member
printer said:
In the paper,

"In the late 1980s, reports had emerged that German physicians were successfully treating HIV patients with 03-AHT (Autohemotherapy)"

"Canadian authorities authorized the study to test safety and efficacy of 03-AHT in AIDS patients."

Looking up Autohemotherapy - Autohemotherapy, or self-blood therapy, involves the extraction of approximately ½ pint of the patient's blood. Once safely extracted, the blood is mixed with a combination of saline and medical-grade ozone gas before it is returned to the patient through an IV drip over several minutes.

Now, looking up the Canadian study ,

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting

Objectives
A growing body of evidence supports the effectiveness of injectable diacetylmorphine (i.e., heroin) for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll of opioid-associated morbidity and mortality, it remains controversial in some settings. To investigate the possible contribution of heroin-assisted treatment (HAT) to HIV treatment-related outcomes, we sought to estimate the proportion and characteristics of HIV-positive people who inject opioids that might be eligible for HAT in Vancouver, Canada.

ascpjournal.biomedcentral.com

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting - Addiction Science & Clinical Practice

Objectives A growing body of evidence supports the effectiveness of injectable diacetylmorphine (i.e., heroin) for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll of opioid-associated morbidity and mortality, it remains controversial in...
ascpjournal.biomedcentral.com ascpjournal.biomedcentral.com

"To investigate the possible contribution of heroin-assisted treatment (HAT) to HIV treatment-related outcomes"

THE CANADIAN STUDY WAS ABOUT SAFE HEROIN INJECTION SITES TO LIMIT THE SPREAD OF AIDS. NOT THE USE OF OZONE TO TREAT AIDS!!!

So the ozone paper lies about Canadians using ozone to treat patients. Or maybe they did not lie, they just did not bother to read the paper other than the Canadians use the same letters HAT, rather than AHT. It is pretty easy how the ozone people could get this wrong, sipping on O3 for too long.

It is funny that the ozone people did not include the Canadian authorization in their references. Must have slipped up I guess.
Click to expand...
Hahahaha!!! Thanks for that!
 
C

cancerkiller

Well-Known Member
pubmed.ncbi.nlm.nih.gov

Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression - PubMed

Acute Respiratory Distress Syndrome (ARDS) causes up to 40% mortality in humans and is difficult to treat. ARDS is also one of the major triggers of mortality associated with coronavirus-induced disease (COVID-19). We used a mouse model of ARDS induced by Staphylococcal enterotoxin B (SEB)...
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
 
Bublonichronic

Bublonichronic

Well-Known Member
Alter Jean said:
Ok. No sides here because the picture is confusing. That dude in the bottom left just caught a load in his mouth from Jesus
Click to expand...
How about this, do some research on how long vaccine trial typically last and how long the COVID trials lasted(were still in them) then make your decision
 
CunningCanuk

CunningCanuk

Well-Known Member
Alter Jean said:
Well that comment is confusing to quote because I was responding to two people who contradicted each other right when I was deciding
Click to expand...
When PJ isn’t cherry picking information to help validate his fears, he’s a rodeo clown.

The only advice I’d ask him for is on quick methods of entry into a whisky barrel.
 
hanimmal

hanimmal

Well-Known Member
Bublonichronic said:
How about this, do some research on how long vaccine trial typically last and how long the COVID trials lasted(were still in them) then make your decision
Click to expand...
Better yet, if anyone is confused ask your real doctor and not think that you can wade through all the propangda online that death cult trolls spread so they can earn those dimes.

https://apnews.com/article/years-research-groundwork-covid-19-shots-f204192f07cfcc3503dc9c7687ae6269
Screen Shot 2021-07-10 at 8.39.58 PM.png
How could scientists race out COVID-19 vaccines so fast without cutting corners? A head start helped -- over a decade of behind-the-scenes research that had new vaccine technology poised for a challenge just as the coronavirus erupted.

“The speed is a reflection of years of work that went before,” Dr. Anthony Fauci, the top U.S. infectious disease expert, told The Associated Press. “That’s what the public has to understand.”

Creating vaccines and having results from rigorous studies less than a year after the world discovered a never-before-seen disease is incredible, cutting years off normal development. But the two U.S. frontrunners are made in a way that promises speedier development may become the norm -- especially if they prove to work long-term as well as early testing suggests.

“Abject giddiness,” is how Dr. C. Buddy Creech, a Vanderbilt University vaccine expert, described scientists’ reactions when separate studies showed the two candidates were about 95% effective.

“I think we enter into a golden age of vaccinology by having these types of new technologies,” Creech said at a briefing of the Infectious Diseases Society of America.

Both shots -- one made by Pfizer and BioNTech, the other by Moderna and the National Institutes of Health -- are so-called messenger RNA, or mRNA, vaccines, a brand-new technology. U.S. regulators are set to decide this month whether to allow emergency use, paving the way for rationed shots that will start with health workers and nursing home residents.

Billions in company and government funding certainly sped up vaccine development — and the unfortunately huge number of infections meant scientists didn’t have to wait long to learn the shots appeared to be working.

But long before COVID-19 was on the radar, the groundwork was laid in large part by two different streams of research, one at the NIH and the other at the University of Pennsylvania — and because scientists had learned a bit about other coronaviruses from prior SARS and MERS outbreaks.

“When the pandemic started, we were on a strong footing both in terms of the science” and experience handling mRNA, said Dr. Tal Zaks, chief medical officer of Massachusetts-based Moderna.

Traditionally, making vaccines required growing viruses or pieces of viruses — often in giant vats of cells or, like most flu shots, in chicken eggs — and then purifying them before next steps in brewing shots.

The mRNA approach is radically different. It starts with a snippet of genetic code that carries instructions for making proteins. Pick the right virus protein to target, and the body turns into a mini vaccine factory.

“Instead of growing up a virus in a 50,000-liter drum and inactivating it, we could deliver RNA and our bodies make the protein, which starts the immune response,” said Penn’s Dr. Drew Weissman.

Fifteen years ago, Weissman’s lab was trying to harness mRNA to make a variety of drugs and vaccines. But researchers found simply injecting the genetic code into animals caused harmful inflammation.

Weissman and a Penn colleague now at BioNTech, Katalin Kariko, figured out a tiny modification to a building block of lab-grown RNA that let it slip undetected past inflammation-triggering sentinels.

“They could essentially make a stealth RNA,” said Pfizer chief scientific officer Dr. Philip Dormitzer.

Other researchers added a fat coating, called lipid nanoparticles, that helped stealth RNA easily get inside cells and start production of the target protein.

Meanwhile at the NIH, Dr. Barney Graham’s team figured out the right target — how to use the aptly named “spike” protein that coats the coronavirus to properly prime the immune system.

The right design is critical. It turns out the surface proteins that let a variety of viruses latch onto human cells are shape-shifters — rearranging their form before and after they’ve fused into place. Brew a vaccine using the wrong shape and it won’t block infection.

“You could put the same molecule in one way and the same molecule in another way and get an entirely different response,” Fauci explained.

That was a discovery in 2013, when Graham, deputy director of NIH’s Vaccine Research Center, and colleague Jason McLellan were investigating a decades-old failed vaccine against RSV, a childhood respiratory illness.

They homed in on the right structure for an RSV protein and learned genetic tweaks that stabilized the protein in the correct shape for vaccine development. They went on to apply that lesson to other viruses, including researching a vaccine for MERS, a COVID-19 cousin, although it hadn’t gotten far when the pandemic began.

“That’s what put us in a position to do this rapidly,” Graham told the AP in February before the NIH’s vaccine was first tested in people. “Once you have that atomic-level detail, you can engineer the protein to be stable.”

Likewise, Germany’s BioNTech in 2018 had partnered with New York-based Pfizer to develop a more modern mRNA-based flu vaccine, giving both companies some early knowledge about how to handle the technology.

“This was all brewing. This didn’t come out of nowhere,” said Pfizer’s Dormitzer.

Last January, shortly after the new coronavirus was reported in China, BioNTech CEO Ugur Sahin switched gears and used the same method to create a COVID-19 vaccine.

Moderna also was using mRNA to develop vaccines against other germs including the mosquito-borne Zika virus -- research showing promise but that wasn’t moving rapidly since the Zika outbreak had fizzled.

Then at the NIH, Graham woke up on Saturday Jan. 11 to see Chinese scientists had shared the genetic map of the new coronavirus. His team got to work on the right-shaped spike protein. Days later, they sent Moderna that recipe -- and the vaccine race was on.
Click to expand...
 
hanimmal

hanimmal

Well-Known Member
Bublonichronic said:
Then you quote AP news, you don’t see the irony unfortunately
Click to expand...
Yup. I was going to put this on that post, but I figured you would trigger with that stupid response about the most non-biased and factually correct information resource, because dictators don't like actual information being able to get through to their cults.

Screen Shot 2021-07-10 at 8.49.37 PM.png

Bublonichronic said:
So you can just say is Russian propaganda , how about you do your own research and not just take what faucci(a habitual liar) and CNN/AP tell you
Click to expand...
lmao because you say so?

I love how trolls pretend that people who haven't dedicated years to these fields are able to just 'research' shit like deadly viruses and actually know what is actual information and what is slickly designed propaganda.
 
You must log in or register to reply here.
Top